WTR Small-Cap Spotlight

Send us Fan Mail In this special episode of the WTR Small-Cap Spotlight Podcast, Jeff Karcher, Global Managing Director of the Texas Stock Exchange (TXSE), joins host Tim Gerdeman, Vice Chair & Co-Founder of Water Tower Research . With its highly anticipated launch planned for 2026, TXSE is positioning itself as a transformative force in U.S. capital markets. Backed by leading investors includ...

Send us Fan Mail In this episode of WTR Small Cap Spotlight, host Tim Gerdeman, Vice Chair, Co-Founder and Chief Marketing Office of Water Tower Research is joined with Alex Verge, President & CEO of Journey Energy and Managing Director in Energy, Chris Degner for a discussion on Journey’s growth investments in the in the Duvernay Shale. The conversation covers the economics of recent wells br...

Send us Fan Mail In this episode of WTR Small-Cap Spotlight , host Shawn Severson, CEO and Co-Founder of Water Tower Research, is joined by Herbalife CFO John DeSimone and WTR’s Head of Consumer Products Equity Research Doug Lane for an in-depth discussion on Herbalife’s improving business trends, strategic product and technology launches, and capital allocation priorities. The conversation covers...

Send us Fan Mail CEO Brent Lucas of Envoy Medical (NASDAQ: COCH), an innovative hearing health technology company and sole US-domiciled cochlear implant company  joins the WTR Small-Cap Spotlight podcast to talk about hearing loss, the third most chronic physical condition prevalent in the US, and how  Envoy's innovative device technology can disrupt the hearing solutions market that has long...

Send us Fan Mail The passage of the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act, signed into law on July 18, 2025, represents a landmark moment for cryptocurrency regulation in the United States. Hear from leaders in crypto like Galaxy Digital and BTCS, and miners like Greenidge, BitFuFu, and Soluna on the near term and long term impacts of the US legislation.

Send us Fan Mail In this special Flashcast episode of the WTR Small-Cap Spotlight, host Tim Gerdeman sits down with Dr. John Roy to explore the explosive trend of companies raising significant capital specifically to invest in cryptocurrency—a hot topic recently featured in the Wall Street Journal. They dive into the staggering scale of this trend, with nearly 100 companies announcing plans to rai...

Send us Fan Mail In this episode of our WTR Small Cap Spotlight, we sat down with LifeVantage (NASDAQ: LFVN ) CEO Steve Fife and CMO Julie Boyster to drill down on the science of nutrigenomics, which is the study of how nutrients impact our genes, and how LifeVantage’s proprietary formulations of naturally found ingredients work together to activate genes and help improve overall health and wellbe...

Send us Fan Mail In this special edition of the WTR Small-Cap Spotlight Flashcast, host Tim Gerdeman sits down with Chris Degner, Managing Director in Water Tower Research’s Energy Practice, to explore major shifts in the oil and natural gas markets. The discussion covers rising OPEC production, evolving global supply structures, and a deep dive into LNG market trends—including emerging export pro...

Send us Fan Mail In this 2nd episode or our two-part WTR Symposium Series podcast, "NEXT-GEN VEHICLES: Investing in Small Drones and Unmanned Vehicles", senior management of Arrive AI (ARAI), Nauticus Robotics (KITT), Ocean Power Technologies (OPTT), and Palladyne AI (PDYN) join the Water Tower Research team including Founding Partner and CEO, Shawn Severson, Managing Director - Energy T...

Send us Fan Mail In our latest WTR-Small-Cap Spotlight podcast, we were joined by Jack Lu,  Director of corporate Development at Ainos (NASDAQ: AIMD) to discuss the company's pioneering smell digitization AI technology platform, AI Nose; diversification of the platform's penetration across multiple verticals through strategic partnerships;  commercialization opportunities and expansion g...

Send us Fan Mail In this episode of WTR Small-Cap x Healthcare Spotlight crossover episode, we are joined by Lisata Therapeutics' (NASDAQ: LSTA) CEO David Mazzo, PhD and Chief Medical Officer Kristen Buck, MD to talk about, Certepetide, the company's novel solid tumor targeting and penetration technology with tumor microenvironment modifying properties.  We also dive into the recently re...

Send us Fan Mail In this two-part WTR Symposium Series podcast, "NEXT-GEN VEHICLES: Investing in Small Drones and Unmanned Vehicles", management of Micropolis Holding Company (MCRP), Ondas Holdings Inc. (ONDS), SES AI Corp, (SES) and Unusual Machines, Inc. (UMAC) join the Water Tower Research team including Founding Partner and CEO, Shawn Severson and Managing Director - Technology, Dr....

Send us Fan Mail In our latest WTR Small-Cap Spotlight x Healthcare Crossover , Cybin CEO Doug Drysdale joins Water Tower Research’s Tim Gerdeman and Senior Analyst Robert Sassoon to discuss the company's non-traditional financing strategy as it continues to advance its development pipeline. Drysdale also probes into data that highlight advantages that distinguish Cybin's lead program CY...

Send us Fan Mail On this week's episode of the WTR Small-Cap Spotlight, Nir Brenmiller, Chief Operating Officer, Co-Founder and Director at Brenmiller Energy (NASDAQ ticker BNRG), joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainable Investing Analyst at Water Tower Research to discuss: 1) the company’...

Send us Fan Mail In Part 2 of our WTR Small-Cap Spotlight Executive Series with SurgePays (NASDAQ: SURG), we continue our conversation with President Derron Winfrey—shifting focus from the company’s mobile virtual network enabler (MVNE) platform to its flagship mobile virtual network operator (MVNO) business, LinkUp Mobile. This episode explores how SurgePays is expanding affordable wireless acces...

Send us Fan Mail In this episode of the WTR Small-Cap | Biotech Spotlight Crossover , Water Tower Research’s Tim Gerdeman is joined by Dr. Chris Witowski , CEO of Psilera , and WTR Senior Analyst Robert Sassoon for an insightful discussion on the company’s pioneering work in neuroplastogen drug development and delivery technologies. Dr. Chris  Witowski, CEO and Co-Founder of Psilera, an early-stag...

Send us Fan Mail In this WTR Symposium Series podcast, " CATCH THE WAVE: Investing in Water Treatment and Solutions ", management of Arq, Inc. (ARQ), California Water Service (CWT), National Energy Services Reunited (NESR), and Select Water Solutions (WTTR) join the Water Tower Research team including Shawn Severson, CEO and Co-founder, Jeff Robertson, Managing Director – Natural Resourc...

Send us Fan Mail On this week's episode of the WTR Small-Cap Spotlight, Mihir Dange, CEO of XCF Global and Simon Oxley, CFO of XCF Global, joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainability Analyst at Water Tower Research to discuss: 1) XCF Global as the first publicly listed pure-play sustainabl...

Send us Fan Mail On this week's episode of the WTR Small-Cap Spotlight, Roshan Pujari, Executive Chairman and CEO of Stardust Power joined Tim Gerdeman, Vice Chair & Co-Founder and Chief Marketing Officer of Water Tower Research, and Peter Gastreich, Energy and Sustainability Analyst at Water Tower Research to discuss: 1) the critical need for developing domestic lithium refining capacity...

Send us Fan Mail Enlivex Therapeutics CEO Oren Hershkovitz, PhD joins us on another WTR Small-Cap x Biotech Spotlight crossover episode to talk about how the company’s cell therapy, Allocetra, reprograms macrophages to treat inflammatory diseases. We dive into the recent Phase 1 data in knee osteoarthritis and what to expect from the randomized Phase 2 readout later this year, as well as the marke...

Send us Fan Mail On this week’s WTR Small-Cap Spotlight, we speak with Apimeds CEO Erik Emerson about the newly NYSE listed company and the development of Apitox, a purified honeybee venom, for knee osteoarthritis and multiple sclerosis. We discuss the therapeutic properties of bee venom and the clinical/regulatory plans to bring Apitox to the US market. Listen to learn more about Apimeds and its...

Send us Fan Mail On our latest episode of Small-Cap Spotlight, WTR Co-Founder Tim Gerdeman, sits down with Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group, to break down the upcoming launch of OTCID and what it means for the future of small-cap investing. 

Send us Fan Mail On this week's episode of Small-Cap Spotlight, WTR's Tim Gerdeman and Dmitry Silversteyn sit down with Howard Klein, Founder of RK Equity. With low metal prices all but precluding equity-based capital, miners and developers are looking to strategics and governments for funding to bridge the gap to the next upcycle.

Send us Fan Mail Jindalee Lithium’s CEO Ian Rodger discusses the company’s McDermitt lithium resource in the context of developing a robust domestic critical metals ecosystem and provides an outline of milestones and deliverables stakeholders can look forward to as JLL  moves the project up the value chain. 

Send us Fan Mail SURG is excited about the opportunity to offer backend support, access to carrier network, and potentially, even outsourced customer care to virtual MVNOs that may have large subscriber bases, but don't have a direct relationship with a carrier. This Mobile Virtual Network Enabler (MVNE) market has opened up to SURG primarily because of its recent direct partnership with AT&a...